Trial Profile
Safety, pharmacokinetics and pharmacodynamics of inclacumab in healthy subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 22 Mar 2016
Price :
$35
*
At a glance
- Drugs Inclacumab (Primary)
- Indications Cardiovascular disorders
- Focus Adverse reactions; First in man; Pharmacodynamics; Pharmacokinetics
- 22 Mar 2016 New trial record